Use of Liposomal Bupivacaine in Pediatric Peripheral Nerve Blocks after Traumatic Amputation

Liposomal bupivacaine has been explored for indications in regional anesthesia, but little has been reported about its use in pediatric patients. In March 2021, the FDA approved an indication for liposomal bupivacaine as an infiltrated local anesthetic in children older than the age of six. Despite...

Full description

Saved in:
Bibliographic Details
Main Authors: Gregory M. Halenda, Stylianos Voulgarelis
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Case Reports in Anesthesiology
Online Access:http://dx.doi.org/10.1155/2021/8092204
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560664621613056
author Gregory M. Halenda
Stylianos Voulgarelis
author_facet Gregory M. Halenda
Stylianos Voulgarelis
author_sort Gregory M. Halenda
collection DOAJ
description Liposomal bupivacaine has been explored for indications in regional anesthesia, but little has been reported about its use in pediatric patients. In March 2021, the FDA approved an indication for liposomal bupivacaine as an infiltrated local anesthetic in children older than the age of six. Despite this recently expanded indication, the literature lacks reports of use for peripheral nerve blockade in children. We describe a case where liposomal bupivacaine was used for femoral and sciatic nerve blocks in a 5-year-old child with traumatic amputation of his lower leg. Pain control was excellent, with no pain or opioid use reported during the first 62 hours. After the regional anesthesia subsided, the patient required in total 4 oral doses of oxycodone 0.1 mg/kg prior to discharge. The patient did not develop chronic pain or phantom limb syndrome. While liposomal bupivacaine is not currently FDA-approved for peripheral nerve blockade in children, this case highlights a potentially effective use of this drug and possible area for further investigation.
format Article
id doaj-art-51cd8b2446b140b9a2719b61e0a94ba0
institution Kabale University
issn 2090-6382
2090-6390
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Case Reports in Anesthesiology
spelling doaj-art-51cd8b2446b140b9a2719b61e0a94ba02025-02-03T01:26:58ZengWileyCase Reports in Anesthesiology2090-63822090-63902021-01-01202110.1155/2021/80922048092204Use of Liposomal Bupivacaine in Pediatric Peripheral Nerve Blocks after Traumatic AmputationGregory M. Halenda0Stylianos Voulgarelis1Department of Anesthesiology, Division of Pediatric Anesthesiology, Children’s of Wisconsin, Medical College of Wisconsin, Milwaukee, Wisconsin, USADepartment of Anesthesiology, Division of Pediatric Anesthesiology, Children’s of Wisconsin, Medical College of Wisconsin, Milwaukee, Wisconsin, USALiposomal bupivacaine has been explored for indications in regional anesthesia, but little has been reported about its use in pediatric patients. In March 2021, the FDA approved an indication for liposomal bupivacaine as an infiltrated local anesthetic in children older than the age of six. Despite this recently expanded indication, the literature lacks reports of use for peripheral nerve blockade in children. We describe a case where liposomal bupivacaine was used for femoral and sciatic nerve blocks in a 5-year-old child with traumatic amputation of his lower leg. Pain control was excellent, with no pain or opioid use reported during the first 62 hours. After the regional anesthesia subsided, the patient required in total 4 oral doses of oxycodone 0.1 mg/kg prior to discharge. The patient did not develop chronic pain or phantom limb syndrome. While liposomal bupivacaine is not currently FDA-approved for peripheral nerve blockade in children, this case highlights a potentially effective use of this drug and possible area for further investigation.http://dx.doi.org/10.1155/2021/8092204
spellingShingle Gregory M. Halenda
Stylianos Voulgarelis
Use of Liposomal Bupivacaine in Pediatric Peripheral Nerve Blocks after Traumatic Amputation
Case Reports in Anesthesiology
title Use of Liposomal Bupivacaine in Pediatric Peripheral Nerve Blocks after Traumatic Amputation
title_full Use of Liposomal Bupivacaine in Pediatric Peripheral Nerve Blocks after Traumatic Amputation
title_fullStr Use of Liposomal Bupivacaine in Pediatric Peripheral Nerve Blocks after Traumatic Amputation
title_full_unstemmed Use of Liposomal Bupivacaine in Pediatric Peripheral Nerve Blocks after Traumatic Amputation
title_short Use of Liposomal Bupivacaine in Pediatric Peripheral Nerve Blocks after Traumatic Amputation
title_sort use of liposomal bupivacaine in pediatric peripheral nerve blocks after traumatic amputation
url http://dx.doi.org/10.1155/2021/8092204
work_keys_str_mv AT gregorymhalenda useofliposomalbupivacaineinpediatricperipheralnerveblocksaftertraumaticamputation
AT stylianosvoulgarelis useofliposomalbupivacaineinpediatricperipheralnerveblocksaftertraumaticamputation